Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Firm Income Reported for This Client
$185K
Not substituted for client expenses
Summary
AMYRIS BIOTECH is an organization. Its political footprint includes $185K in lobbying-firm income reported for this client. Lobbying activity focuses on Fuel/Gas/Oil, Environment/Superfund, Taxation/Internal Revenue Code. Political activity spans from 2007 to 2009.